Sponsor:
Zydus Therapeutics Inc.
Code:
NCT05045482
Conditions
Hepatic Impairment
Cirrhosis
Cholestatic Liver Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Saroglitazar Magnesium 1 mg
Saroglitazar Magnesium 2 mg
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-30. This information was provided to ClinicalTrials.gov by Zydus Therapeutics Inc. on 2025-08-15.